Professional Documents
Culture Documents
Slow recovery in Ship Building to dampen margin growth - Ship building, however,
Key indicators
faced a significant downfall during 3Q FY19 with revenue halved from a year earlier to FY 18 FY 19E FY 20E FY 21E
LKR 683mn. The segmental contribution to the top line dropped to 27% from 43% in 3Q
EBIT margin (%) 1.0% -14.5% -6.9% -3.92%
FY18 with the delivery of the Cabel laying vessel in July 2019. Hence, revenue recognition
from the two pilot vessels for SL Port Authority (delivered in December) and two Buoy ROE (%) 3.3% -16.9% -6.0% -1.4%
tender ships for the client from Iraq will account for majority of the revenue recognized in P/E (x) 12.0x nm nm nm
4Q FY19. However, high price competition among small scale ship builders resulted in P/BV (x) 0.4x 0.4x 0.5x 0.5x
DOCK securing new contracts worth less than LKR 1bn in 2019 and we have not factored
in any new projects which are at negotiation stage in our valuation. This includes negotia- EPS (LKR) 4.61 (22.10) (6.93) (1.53)
tions with a European client and on few state sector projects, with the latter on hold
amidst recent changes in the political front.
ASPI vs DOCK
Outlook - With the two Buoy tender ships scheduled to be delivered in 3Q 2020E, we ASPI (LHS) DOCK (RHS)
6,750 65
envisage Ship repair will act as the main cash generating segment during our forecast
period. However, assuming the best case scenario, if DOCK secures the European project 6,500
60
to build six bulk carriers, it will form most part of the revenue from 2020E-2022E. Price
6,250
negotiations related to the project are still ongoing which the company expects to final-
55
ise towards end of February. However, given the thin margins and high price competition 6,000
affecting feasibility of the project, the impact to the CMP is calculated at less than 5%.
5,750 50
Hence, this will not trigger a change in our recommendation.
5,500
45
Valuation: - Intense price competition, eroding margins under the ship building segment 5,250
and oil prices still struggling to establish a sustained upward momentum with the corona
5,000 40
virus outbreak would impact the group’s overall performance in our view. Taking above
Feb-19 Apr-19 Jun-19 Aug-19 Oct-19 Dec-19
factors into consideration, we have arrived at a DCF based valuation TP of LKR 46.57 with
a downside of 11.1% on CMP.
3Q 19 3Q 18
(LKR 'mn) Gross Profit GP Margin Gross Profit GP Margin
Ship Repair 132 9.3% 0 0.0%
Ship Building (87) -12.7% 167 9.6%
Heavy Engineering 71 17.1% 102 33.0%
Material Sales 16 33.7% 22 8.5%
10%
24%
India
Singapore
Sri Lanka
44% 41%
Japan
Other
12%
Valuation estimates
DCF based valuation results in a TP of LKR 46.57, with a downside of 11.1% on CMP. Key assumptions used in
the valuation are as follows;
Valuation sensitivity
EBIT including non-recurring items (299,470) (154,103) 152,389 (1,728,021) (741,909) (398,467)
Non-recurring items (1,528) 5,244 1,610 - - -
EBIT excluding non-recurring items (297,942) (159,347) 150,779 (1,728,021) (741,909) (398,467)
YoY growth % -51.2% -46.5% -194.6% -1246.1% -57.1% -46.3%
EBITDA excluding non-recurring items 161,850 274,768 583,538 (1,256,571) (239,143) 94,718
YoY growth % -203.1% 69.8% 112.4% -315.3% -81.0% 139.6%
Recurring profit before tax (246,812) 130,420 459,279 (1,439,521) (447,360) (103,287)
YoY growth % -54.0% -152.8% 252.2% -413.4% -68.9% -76.9%
Income tax expense (40,723) (109,570) (123,414) (143,952) (44,736) (5,164)
Profit after taxation (Recurring) (287,535) 20,850 335,865 (1,583,473) (492,096) (108,452)
YoY growth % -51.9% -107.3% 1510.9% -571.5% -68.9% -78.0%
Earnings per share - BRS adjusted (1) (4.02) 0.35 4.61 (22.10) (6.93) (1.53)
EPS Reported (2) (4.05) 0.35 4.61 - - -
Note 1: EPS adjusted for share split, consolidations and non recurring information
Note 2: Based on earnings as reported (unadjusted for non-recurring) share data adjusted for splits
5
Balance sheet - December ended
All numbers in LKR '000 2016 2017 2018 2019E 2020E 2021E
Current Assets
Inventories 1,310,425 745,516 821,934 596,522 536,477 508,700
Trade and Other Receivables 11,228,832 7,179,216 5,823,456 5,010,788 4,506,409 4,273,083
Other financial Assets including Derivatives 150,648 164,764 243,155 243,155 243,155 243,155
Cash and Cash Equivalents 2,665,157 5,060,826 4,914,690 4,005,122 3,791,220 3,930,900
15,503,317 13,676,007 12,039,360 10,091,713 9,313,386 9,191,964
Current Liabilities
Trade and Other payables 2,054,263 3,778,412 3,008,839 2,863,308 2,575,091 2,441,762
Interest Bearing Borrowings 7,409,743 3,494,446 2,712,300 2,812,297 2,912,294 3,012,291
Other financial Liabilities including Derivatives 18,617 - - - - -
Tax Provision 56,286 34,623 83,968 109,402 73,986 37,992
Dividends payable 26,191 26,152 15,152 15,152 15,152 15,152
Bank Overdrafts 12,804 2,204 80 83 86 89
9,577,904 7,335,837 5,820,339 5,800,241 5,576,609 5,507,286
Operating cash flow before changes in working capital 382,454 524,299 806,380 (1,107,171) (89,643) 244,218
Changes in Working Capital (2,304,090) 6,377,080 470,032 892,548 276,208 127,774
Cash generated from Operations (1,921,636) 6,901,379 1,276,412 (214,623) 186,564 371,992
Investing Activities
Purchase of property, plant & equipment (191,052) (208,974) (770,462) (715,827) (536,477) (406,960)
Acquisition of Intangible Assets (39,446) (709) - - - -
Proceeds from disposal of PPE 8,764 7,579 2,531 - - -
Dividends Received - - 10 - - -
Interest Received 154,249 284,369 221,978 335,496 338,235 340,366
Net cash used in investing activities (229,014) (178,092) (315,527) (380,331) (198,242) (66,595)
Financing Activities
Loans obtained / (settled) 11,583,387 6,489,451 6,752,188 100,000 100,000 100,000
Dividends paid (13,397) (39) (118,788) (107,788) (35,929) (35,929)
Net Cash in financing activities 2,816,348 (3,915,336) (900,934) (7,788) 64,071 64,071
Increase/(Decrease) in Cash and Cash Equivalents 302,292 2,455,776 (233,152) (909,568) (213,902) 139,680
Important Disclosures
This report was prepared by Strategic Research Limited for clients of Bartleet Religare Securities.
Special Disclosures
“Special Disclosures” for certain additional disclosure statements (if applicable).
Intended Recipients
This report is intended only for the use of the individual or entity named above and may contain information that is confidential and privileged. It is in-
tended only for the perusal of the individual or entity to whom it is addressed and others who are authorized to receive it. If you are not the intended recipi-
ent of this report, you are hereby on notice that any disclosure, dissemination, distribution, copying or taking action relying on the contents of this informa-
tion is strictly prohibited and illegal.
BRS, is not liable for the accurate and complete transmission of the information contained herein nor any delay in its receipt. If you have received this email
in error, please notify us immediately by return email and please destroy the original message
This report is not intended for citizens (individual or corporate) based in the United States of America.
Analyst Certification
Each of the analysts identified in this report certifies, with respect to the companies or securities that the individual analyses, that the views expressed in this
report reflect his or her personal views about all of the subject companies and all of the securities and No part of his or her compensation was, is or will be
directly or indirectly dependent on the specific recommendations or views expressed in this report. If the lead analyst holds shares of the coverage; that will
be listed here.
Stock Ratings
Recommendation
Buy
More than 10%
Hold
Between 10% and 0
Sell
Less than 0%
Expected absolute returns are based on the share price at market close unless otherwise stated. Stock recommendations are based on absolute upside
(downside) and have a 12-month horizon. Our target price represents the fair value of the stock based upon the analyst’s discretion. We note that future
price fluctuations could lead to a temporary mismatch between upside/downside for a stock and our recommendation.
General Disclaimers
• This report is strictly confidential and is being furnished to you solely for your information purposes.
• The information, tools and material presented in this report are not to be used or considered as an offer or solicitation of an offer to sell or to
purchase or subscribe for securities.
• SRL has not taken any measures to guarantee in any way that the securities referred to herein are suitable investments for any particular investor.
SRL will not under any circumstance, consider recipients as its customers by virtue of them receiving the report. The investments or services con-
tained or referred to in this report may not be suitable for you and it is highly recommended that you consult an independent investment advisor
if you are in any doubt about such investments or related services.
• Further, nothing in this report constitutes investment, legal, accounting or tax advice or a representation that any investment or strategy is suit-
able or appropriate to your individual circumstances, investment needs or otherwise construes a personal recommendation to you.
• Information and opinions presented herein were obtained or derived from sources that SRL believes to be relied upon, but SRL makes no repre-
sentations or warranty, express or implied, as to their accuracy or completeness or correctness.
• SRL accepts no liability whatsoever for any loss arising from the use of the material presented in this report.
• This report is not to be relied upon as a substitute for the exercise of independent judgment. SRL may have issued, and may in the future issue, a
trading call regarding this security. Trading calls are short term trading opportunities based on market events and catalysts, while stock ratings
reflect investment recommendations based on expected absolute return over a 12-month period as defined in the disclosure section. Because
trading calls and stock ratings reflect different assumptions and analytical methods, trading calls may differ directionally from the stock rating.
• Past performance should not be taken as any indication or guarantee of future performance, and no representation or warranty, express or im-
plied, is made regarding future performance.
• Information, opinions and estimates contained in this report reflect a judgment of its original date of publication by SRL and are subject to
change without notice. The price, value of and income from any of the securities or financial instruments mentioned in this report can fall as well
as rise. The value of securities and financial instruments is subject to exchange rate fluctuation that may have a positive or adverse effect on the
price or income of such securities.
• SRL may or may not seek to do business with companies covered in our research report. As a result, investors should be aware that the firm may
have a conflict of interest that could affect the objectivity of research produced by SRL. Investors should consider our research as only a single
factor in making their investment decision.
9